Discovery Labs falls on Surfaxin setback

Discovery Laboratories Inc. (NASDAQ:DSCO) was off $0.54 (52%) to $0.51 on Thursday after announcing late Wednesday that it is unlikely to gain FDA approval of Surfaxin lucinactant to prevent respirato...